Selectively killing transformed cells through proteasome inhibition.

about

Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.

P2860

Q36231919-4F0BEC1A-5BD0-4E3F-8E9D-DD071CE51F70

P2860

Selectively killing transformed cells through proteasome inhibition.

Item

http://www.wikidata.org/entity/Q43089411

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Selectively killing transformed cells through proteasome inhibition.

@en

Selectively killing transformed cells through proteasome inhibition.

@nl

type

Item

label

Selectively killing transformed cells through proteasome inhibition.

@en

Selectively killing transformed cells through proteasome inhibition.

@nl

prefLabel

Selectively killing transformed cells through proteasome inhibition.

@en

Selectively killing transformed cells through proteasome inhibition.

@nl

P1476

Selectively killing transformed cells through proteasome inhibition.

@en

P2093

Steven Grant

http://www.w3.org/2001/XMLSchema#string

P2860

NF-kappaB at the crossroads of life and death

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.

NF-kappa B as a therapeutic target in multiple myeloma.

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.

Drug discovery in the ubiquitin-proteasome system.

Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells

Damage control: DNA repair, transcription, and the ubiquitin-proteasome system.

Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts.

P304

3074-3075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.8.19.9815

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26827946

http://www.w3.org/2001/XMLSchema#string

P698

19770579

http://www.w3.org/2001/XMLSchema#string

P932

3713105

http://www.w3.org/2001/XMLSchema#string

Selectively killing transformed cells through proteasome inhibition.

about

P2860

P2860

Selectively killing transformed cells through proteasome inhibition.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932